We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology

We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology

We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology

The incidence of allergic diseases and asthma is increasing throughout the world, and therefore, these diseases pose major medical and socioeconomic problems globally (1,2). This is particularly true in the developed world, which has experienced a tremendous increase in the prevalence of allergic diseases and asthma over the last 50 years (2–5). Asthma currently affects 8–12% of the population in the developed world, and the prevalence of allergic rhinitis continues to increase and currently affects approximately 20–25% of this same population (6,7). Patients affected by these allergic disease states are recognized to have a poorer quality of life, reduced work productivity and school attendance, comorbidities, and increased healthcare costs (2).

read-online1

Post Comment

Filed in: